Breaking News Instant updates and real-time market news.

GM

General Motors

, F

Ford

09:23
10/06/16
10/06
09:23
10/06/16
09:23

Autos and Autos Parts sector downgraded to Cautious from Neutral at Goldman

Goldman analyst David Tamberrino downgraded the Autos and Auto Parts sector to Cautious from Neutral saying the US Auto cycle peaked in 2015 and is being held up by increasing OEM incentives. The analyst said OEM earnings will decline in 2017/2018 as negative pricing and lower production pressure North American results, but expects suppliers' earnings to hold up longer. The analyst sees upside to Delphi (DLPH) and Harman (HAR) given exposure to secular growth areas and upside to Goodyear Tire (GT) given secular HVA tire growth. Tamberrino downgraded Lear (LEA) to Sell citing elevated expectations and valuation, cut BorgWarner (BWA) to Neutral on valuation, downgraded Tesla (TSLA) to Neutral on execution risk and capital deployment, and upgraded AutoNation (AN) to Neutral given a more defensive business.

GM

General Motors

F

Ford

DLPH

Delphi

HAR

Harman

LEA

Lear

BWA

BorgWarner

TSLA

Tesla

$208.46

-2.95 (-1.40%)

AN

AutoNation

  • 07

    Oct

  • 25

    Oct

  • 26

    Oct

  • 27

    Oct

  • 28

    Oct

  • 31

    Oct

  • 02

    Nov

  • 08

    Nov

  • 17

    Nov

GM General Motors

09/20/16
NOMU
09/20/16
INITIATION
Target $33
NOMU
Neutral
General Motors initiated with a Neutral at Nomura
Nomura analyst Anindya Das initiated General Motors with a Neutral and a $33 price target. The analyst said General Motors has significant exposure to the Chinese auto market and is concerned about pricing pressures in the market. Further, the company has yet to break even in Europe on an annual basis and its near-term prospects are clouded by Brexit uncertainties.
09/19/16
09/19/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. General Motors (GM) upgraded to Overweight from Equal Weight at Morgan Stanley with analyst Adam Jonas saying he believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. 2. Wells Fargo (WFC) upgraded to Outperform from Neutral at Baird analyst David George saying he believes the recent pullback is a buying opportunity. 3. Lockheed Martin (LMT) upgraded to Outperform from Market Perform at Wells Fargo with analyst Sam Pearlstein saying he believes the company's earnings can grow 20% per year through 2020. 4. U.S. Steel (X), AK Steel (AKS), and Olympic Steel (ZEUS) were upgraded to Sector Weight from Underweight at KeyBanc with analyst Ivan Marcuse saying the stocks at current levels better reflect the more competitive market conditions he expects in Q4 and 2017. 5. Mattel (MAT) upgraded to Buy from Neutral at Monness Crespi. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/19/16
09/19/16
UPGRADE
Target $37

Overweight
General Motors upgraded to Overweight at Morgan Stanley
As previously reported, Morgan Stanley upgraded General Motors to Overweight from Equal Weight and increased its price target to $37 from $29. Analyst Adam Jonas raised near-term earnings estimates 5% above consensus and believes even flat earnings in 2017 and 2018 would be received as a positive surprise by the market. Further, the analyst said investors are underestimating how long the auto cycle can last and that General Motor's earnings and free cash flow could have a materially longer duration than the market is currently discounting. He believes investors are overlooking the time and steps needed for fully autonomous transport and said management has a healthy and realistic acceptance that it can't and should not do everything alone and will likely explore new business structures with the potential of positive values.
09/19/16
MSCO
09/19/16
UPGRADE
MSCO
Overweight
General Motors upgraded to Overweight from Equal Weight at Morgan Stanley
F Ford

09/20/16
09/20/16
DOWNGRADE

Neutral
Ford downgraded on an earnings peak at Buckingham
As previously reported, Buckingham downgraded Ford to Neutral from Buy and lowered its price target to $12 from $16. Analyst Joseph Amaturo believes North American volume and pricing trends for trucks will deteriorate and is concerned that the passenger car market will remain challenged given stiff competition from Japanese and European OEMs that can heavily discount due to weak currencies. Amaturo believes the product cycle advantage has run its course and earnings will peak and sees greater than 50% chance of downside earnings risk in 2017 and 2018.
09/20/16
09/20/16
DOWNGRADE

On The Fly: Top five analyst downgrades
Catch up on today's top five analyst downgrades with this list compiled by The Fly: 1. Ford (F) downgraded to Neutral from Buy at Buckingham with analyst Joseph Amaturo saying he believes North American volume and pricing trends for trucks will deteriorate and is concerned that the passenger car market will remain challenged given stiff competition from Japanese and European OEMs that can heavily discount due to weak currencies. 2. General Mills (GIS) downgraded to Underperform from Neutral at Consumer Edge. 3. Ascena Retail (ASNA) downgraded to Sector Perform from Outperform at RBC Capital and to Perform from Outperform at Oppenheimer. 4. Avnet (AVT) downgraded to Hold from Buy at Stifel and to Sell from Hold at Cross Research. 5. HD Supply (HDS) downgraded to Sector Perform from Outperform at RBC Capital with analyst Deane Dray saying it will take several quarters for the company to address its supply chain errors, and she expects the stock "to stay range bound over the medium term." This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
09/20/16
09/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Ford (F) initiated with a Buy at Nomura. 2. Intel (INTC) was initiated with a Positive at Susquehanna while the firm initiated AMD (AMD) with a Neutral. 3. HSN, Inc. (HSNI) initiated with an Underperform at BofA/Merrill. 4. Bojangles (BOJA) initiated with a Strong Buy at CL King. 5. D.R. Horton (DHI) initiated with an Outperform at Wedbush. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/29/16
LOOP
09/29/16
NO CHANGE
Target $115
LOOP
Buy
Loop Capital wonders if Trump is trying to kill Kansas City Southern
Following Monday's presidential debate, Loop Capital analyst Rick Paterson is rethinking his reluctance to believing a potential Donald Trump presidency is a threat to Kansas City Southern's business. Trump opened the debate by attacking Kansas City Southern customer Ford Motor's (F) transplanting of auto assembly plants from the U.S. to Mexico, Paterson tells investors in a research note. KSU was the best performing rail stock and the Mexican peso was 2.5% stronger the day after Hillary Clinton's debate victory, the analyst points out. He views Mexico as a "key growth engine" for both KSU and Union Pacific (UNP). Paterson cites a CNN poll for Clinton's debate victory. The analyst has a Buy rating on KSU with a $115 price target.
DLPH Delphi

08/24/16
KEYB
08/24/16
NO CHANGE
KEYB
Auto stocks oversold, says KeyBanc
KayBanc believes that the shares of light vehicle suppliers and auto retailers are oversold, given the improving labor market and a good economic outlook. The firm identifies Magna (MGA) as one of its "key value ideas" among suppliers and Delphi (DLPH) as one of its "key growth ideas" among suppliers. It calls Lithia Motors (LAD) one of its "key ideas for the retailers." The firm keeps Overweight ratings on all the stocks named.
08/24/16
BARD
08/24/16
NO CHANGE
BARD
Outperform
Baird remains buyer of both Delphi and Mobileye
Baird analyst David Lelker said he remains a buyer of both Delphi (DLPH) and Mobileye (MBLY) following their announcement of a partnership to develop technology for full autonomous driving. The combination forms one of the most formidable collections of technologies needed for self-driving cars, said Lelker, who added that both remain among his top ideas. The analyst reiterated his Outperform rating on both Delphi and Mobileye shares.
08/23/16
EVER
08/23/16
NO CHANGE
EVER
Buy
Mobileye, Delphi partnership positive for both, says Evercore ISI
Evercore ISI analyst Chris McNally said he views Mobileye (MBLY) and Delphi Automotive's (DLPH) automated driving solution partnership as positive for both companies as it clarifies that their efforts are collaborative rather than competitive. McNally keeps a Buy rating on both stocks.
08/09/16
GHSC
08/09/16
INITIATION
Target $77
GHSC
Buy
Delphi initiated with a Buy at Seaport Global
Seaport Global analyst Michael Ward initiated Delphi with a Buy and $77 price target.
HAR Harman

07/22/16
PACS
07/22/16
DOWNGRADE
PACS
Sector Weight
Harman downgraded to Sector Weight from Overweight at Pacific Crest
Pacific Crest analyst Brad Erickson downgraded Harman (HAR) to Sector Weight saying his firm's checks with 33 car deal dealers were negative for the company and mixed for Mobileye (MBLY). Mid-tier car buyers are increasingly opting for lower-cost infotainment systems, which often do not include navigation, Erickson tells investors in a research note. The analyst sees more limited growth opportunities for Harman and views mid-$80s as fair value for the shares.
07/20/16
07/20/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Charter (CHTR) initiated with a Buy at Argus. 2. Panera Bread (PNRA) initiated with an Outperform at RBC Capital. 3. IMAX (IMAX) reinitiated with a Buy at Roth Capital. 4. Harman (HAR) initiated with a Buy at Deutsche Bank. 5. MyoKardia (MYOK) initiated with an Outperform at BMO Capital. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/05/16
BARD
08/05/16
DOWNGRADE
BARD
Neutral
Harman downgraded to Neutral from Outperform at Baird
08/05/16
BARD
08/05/16
DOWNGRADE
Target $87
BARD
Neutral
Harman downgraded to Neutral at Baird
As reported previously, Baird downgraded Harman to Neutral from Outperform. The firm sees a balanced risk/reward, finding it challenging to raise its price target while the company is looking at single digit revenue and earnings growth over the next several quarters. Baird maintained its $87 price target on Harman shares.
LEA Lear

09/08/16
KEYB
09/08/16
NO CHANGE
KEYB
Lear now owns competing technology to Gentherm's, says KeyBanc
KeyBanc analyst st Brett Hoselton views Lear's (LEA) minority interest in Tempronics, and Lear's exclusive rights to its thermoelectric seat heating and cooling technology, as a materially negative read through for Gentherm (THRM). The analyst believes Gentherm's revenue outlook of +10% remains optimistic given Lear is 22% of revenues, margins likely to be impacted given increased sourcing options, and the company's products are increasingly less proprietary and less advanced. Hoselton rates Gentherm a Sector Weight.
09/09/16
JPMS
09/09/16
NO CHANGE
Target $44
JPMS
Overweight
JPMorgan says buy Gentherm following yesterday's selloff
JPMorgan analyst Samik Chatterjee attributes the 8.5% selloff yesterday in shares of Gentherm (THRM) to competitive concerns after seating supplier Lear (LEA) announced a strategic partnership with a start-up stage company called Tempronics. The partnership grants Lear exclusive rights to manufacture and sell thermoelectric seat heating and cooling products using Tempronics technology, Chatterjee tells investors in a research note. The analyst offers 10 reasons to buy shares of Gentherm, including the Tempronics product only being in a "nascent stage" and that the near-term impact to Gentherm's financials will be limited given the long design and product development cycle in. Chatterjee has an Overweight rating on Gentherm with a $44 price target.
08/09/16
GHSC
08/09/16
INITIATION
GHSC
Neutral
Lear initiated with a Neutral at Seaport Global
10/06/16
GSCO
10/06/16
DOWNGRADE
Target $107
GSCO
Sell
Lear downgraded to Sell from Neutral at Goldman
Goldman analyst downgraded David Tamberrino Lear to Sell from Neutral and lowered its price target to $107 from $116. The analyst believes expectations are elevated and are now at the high end of management's guidance. He believes shares are more fairly value and could see a pullback on only achieving current earnings estimates.
BWA BorgWarner

06/21/16
BOFA
06/21/16
DOWNGRADE
Target $39
BOFA
Neutral
BorgWarner downgraded to Neutral from Buy at BofA/Merrill
BofA/Merrill analysts led by John Murphy lowered their U.S. vehicle sales and North American production forecasts given a somewhat slower than expected sales pace so far this year. The firm lowered its 2016 U.S. sales estimate to 17.7M from 18.2M units and its peak estimate to 18M units from 20M units in 2018. As a result, Murphy downgraded BorgWarner to Neutral from Buy given the later stages of the U.S. cycle and elevated long-term risk hybrid and electric vehicles penetrate the market faster than anticipated. The analyst lowered his price target to $39 from $45 on BorgWarner shares.
09/08/16
GSCO
09/08/16
NO CHANGE
GSCO
Goldman's Focus List changes
Goldman added Acuity Brands (AYI) & Facebook (FB) to the Focus List and removed Biogen (BIIB), BorgWarner (BWA), Monsanto (MON), and Grainger (GWW). The bank commented Acuity is a beneficiary of the Low Carbon Economy and said Facebook ranks as a low asset-light tech disruptor that is able to leverage its world-leading user base and mobile users to monetize long-term growth.
08/09/16
GHSC
08/09/16
INITIATION
GHSC
Neutral
BorgWarner initiated with a Neutral at Seaport Global
10/06/16
GSCO
10/06/16
DOWNGRADE
GSCO
Neutral
BorgWarner downgraded to Neutral from Buy at Goldman
Goldman analyst David Tamberrino downgraded BorgWarner to Neutral saying shares are fairly valued and lowered his price target to $35 from $37.
TSLA Tesla
$208.46

-2.95 (-1.40%)

10/03/16
OPCO
10/03/16
NO CHANGE
OPCO
Perform
Review process of SolarCity acquisition may be delayed, says Oppenheimer
Oppenheimer analyst Colin Rusch believes the SEC review process of Tesla's (TSLA) acquisition of SolarCity (SCTY) could be delayed due to recent activity, especially new litigation. Further, the analyst believes extension to the timeline is likely to work against the deal given the risk of ongoing "collaboration to trigger gun-jumping rules." Rusch reiterates a Perform rating on Tesla's shares.
09/28/16
PACS
09/28/16
NO CHANGE
PACS
Outlook mixed for Tesla, says Pacific Crest
After conducting checks, Pacific Crest analyst Brad Erickson says that orders for Tesla's Model X have improved, and he expects the company's Q3 deliveries to be "solid." However, he believes that the company is offering "aggressive" discounts on Model 3 vehicles, and he thinks the company "faces overall ASP and margin risk," along with a questionable long-term demand outlook. Erickson remains cautious on the stock and keeps a Sector Weight rating on the shares.
09/28/16
BARD
09/28/16
NO CHANGE
Target $338
BARD
Outperform
Baird estimates Tesla to report 21,000 deliveries for Q3
Baird analyst Ben Kallo said he expects Tesla (TSLA) to report its Q3 delivery figures by early next week, possibly on Monday, October 3, and he estimates the company will report 21,000 total deliveries, including 12,000 Model S deliveries and 9,000 Model X deliveries. Kallo thinks a delivery number above 20,000 vehicles will be viewed as positive and believes "shorts may return" to Tesla after the delivery announcement as the company's acquisition of SolarCity (SCTY)progresses. The analyst keeps an Outperform rating and $338 price target on Tesla shares.
10/06/16
GSCO
10/06/16
DOWNGRADE
GSCO
Neutral
Tesla downgraded to Neutral from Buy at Goldman
Goldman analyst David Tamberrino downgraded Tesla to Neutral and lowered his price target to $185 from $240. Tamberrino sees incremental risk to Tesla's business related to management's willingness to deploy capital for M&A, and he believes that any delay in the company's new Model 3 launch will be detrimental to shares. The analyst said there is room for downward estimate revisions as volume ramps slower and spending grows. Tamberrino's 2016 earnigns estimate of (59c) is above the Street's (93c), but estimates for 2017 through 2019 are on average 48% below consensus.
AN AutoNation

09/08/16
09/08/16
INITIATION

On The Fly: Top analyst initiations
Catch up on today's top analyst initiations with this list compiled by The Fly: 1. Tesla (TSLA) initiated with an Underperform, $160 target at Cowen with analyst Jeffrey Osborne saying the company is well positioned for the long term but has a "material amount of execution risk" over the next 12 to 18 months. 2. AutoNation (AN) initiated with a Buy at CL King. 3. Wingstop (WING) initiated with an Overweight at KeyBanc. 4. Vivint Solar (VSLR), Sunrun (RUN), and SolarEdge (SEDG) initiated with an Outperform at JMP Securities with the firm initiated First Solar (FSLR) and SunPower (SPWR) with an Underperform. The firm also initiated Canadian Solar (CSIQ) with a Market Perform. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
09/07/16
KING
09/07/16
INITIATION
Target $57
KING
Buy
AutoNation initiated with a Buy at CL King
CL King analyst William Armstrong initiated AutoNation with a Buy rating and $57 price target.
08/31/16
WOLF
08/31/16
INITIATION
WOLF
Peer Perform
AutoNation initiated with a Peer Perform at Wolfe Research
10/06/16
GSCO
10/06/16
UPGRADE
GSCO
Neutral
AutoNation upgraded to Neutral from Sell at Goldman
Goldman analyst David Tamberrino upgraded AutoNation to Neutral and lowered its price target to $49 from $52 saying valuation has bottomed and and could be flat to slightly up in the near-term as SAAR bounces around the low-to-mid 17M range.

TODAY'S FREE FLY STORIES

ESRX

Express Scripts

$61.00

-1.01 (-1.63%)

14:25
09/20/17
09/20
14:25
09/20/17
14:25
Options
Express Scripts call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 25

    Oct

14:25
09/20/17
09/20
14:25
09/20/17
14:25
General news
FX Action: The dollar rose, then fell, then rose again »

FX Action: The dollar…

14:25
09/20/17
09/20
14:25
09/20/17
14:25
Conference/Events
Federal Reserve Chairperson Yellen holds a press conference »

Following a quarterly…

CVS

CVS Health

$81.68

-1.42 (-1.71%)

, WBA

Walgreens Boots Alliance

$81.21

-1.39 (-1.68%)

14:20
09/20/17
09/20
14:20
09/20/17
14:20
Hot Stocks
Pharmacies drop after Leerink says Amazon talking to PBMs »

After speaking with…

CVS

CVS Health

$81.68

-1.42 (-1.71%)

WBA

Walgreens Boots Alliance

$81.21

-1.39 (-1.68%)

AMZN

Amazon.com

$969.86

-4.33 (-0.44%)

ESRX

Express Scripts

$61.00

-1.01 (-1.63%)

ABC

AmerisourceBergen

$78.74

-0.54 (-0.68%)

CAH

Cardinal Health

$66.44

0.179 (0.27%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 17

    Oct

  • 22

    Oct

  • 25

    Oct

ALNY

Alnylam

$75.04

-0.96 (-1.26%)

14:20
09/20/17
09/20
14:20
09/20/17
14:20
Recommendations
Alnylam analyst commentary  »

Alnylam price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

14:20
09/20/17
09/20
14:20
09/20/17
14:20
General news
Treasury Action: yields knee-jerked higher »

Treasury Action: yields…

$NSD

NASDAQ Market Internals

14:17
09/20/17
09/20
14:17
09/20/17
14:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

14:16
09/20/17
09/20
14:16
09/20/17
14:16
Technical Analysis
NYSE market internals summary »

Volume is below average…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SWKS

Skyworks

$107.93

0.44 (0.41%)

14:15
09/20/17
09/20
14:15
09/20/17
14:15
Options
Skyworks put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Oct

14:15
09/20/17
09/20
14:15
09/20/17
14:15
General news
FOMC announced balance sheet runoff in October and left rates unchanged »

FOMC announced balance…

14:15
09/20/17
09/20
14:15
09/20/17
14:15
General news
Breaking General news story  »

Fed Chair Press…

SPY

SPDR S&P 500 ETF Trust

$249.89

-0.08 (-0.03%)

, SPX

S&P 500

14:13
09/20/17
09/20
14:13
09/20/17
14:13
Technical Analysis
Technical View: S&P 500 slips below the pivot low »

The S&P 500 (SPX) is…

SPY

SPDR S&P 500 ETF Trust

$249.89

-0.08 (-0.03%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PZRX

PhaseRx

$0.78

0.055 (7.64%)

14:11
09/20/17
09/20
14:11
09/20/17
14:11
Hot Stocks
PhaseRx confirms receipt of FDA orphan drug designation for PRX-ASL »

PhaseRx announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SNY

Sanofi

$49.34

0.24 (0.49%)

14:10
09/20/17
09/20
14:10
09/20/17
14:10
Hot Stocks
Sanofi reports 'potential breakthrough' in preclinical work on HIV antibodies »

Researchers working…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Oct

SPX

S&P 500

14:06
09/20/17
09/20
14:06
09/20/17
14:06
General news
Fed details plans to being reducing balance sheet »

The Federal Reserve said…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

VRX

Valeant

$14.06

0.29 (2.11%)

14:05
09/20/17
09/20
14:05
09/20/17
14:05
Options
Valeant call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 02

    Oct

SPY

SPDR S&P 500 ETF Trust

$249.87

-0.1 (-0.04%)

, SPX

S&P 500

14:04
09/20/17
09/20
14:04
09/20/17
14:04
General news
Federal Reserve maintains median projection for year-end funds rate at 1.4% »

The Fed's "dot…

SPY

SPDR S&P 500 ETF Trust

$249.87

-0.1 (-0.04%)

SPX

S&P 500

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPX

S&P 500

14:02
09/20/17
09/20
14:02
09/20/17
14:02
General news
Fed says economic activity rising moderately this year »

The Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SPLK

Splunk

$68.25

-0.24 (-0.35%)

, SYMC

Symantec

$34.16

0.39 (1.15%)

14:02
09/20/17
09/20
14:02
09/20/17
14:02
Periodicals
Breaking Periodicals news story on Splunk, Symantec »

Symantec 'play'…

SPLK

Splunk

$68.25

-0.24 (-0.35%)

SYMC

Symantec

$34.16

0.39 (1.15%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Oct

SPX

S&P 500

14:01
09/20/17
09/20
14:01
09/20/17
14:01
General news
Fed plans to initiate balance sheet normalization in October »

The Federal…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

14:01
09/20/17
09/20
14:01
09/20/17
14:01
General news
FOMC Meeting Announcement Federal Funds Rate data reported »

FOMC Meeting Announcement…

14:00
09/20/17
09/20
14:00
09/20/17
14:00
General news
Breaking General news story  »

Federal Reserve leaves…

RNVA

Rennova Health

$0.22

-0.0021 (-0.93%)

13:55
09/20/17
09/20
13:55
09/20/17
13:55
Conference/Events
Rennova Health to host special shareholder meeting »

Special Shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

MLCO

Melco Resorts & Entertainment

$23.78

0.77 (3.35%)

13:50
09/20/17
09/20
13:50
09/20/17
13:50
Options
Bullish option play opened in Melco Resorts as shares tick to 52-week highs »

Bullish option play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

MOH

Molina Healthcare

$62.33

0.21 (0.34%)

, UNH

UnitedHealth

$195.34

0.69 (0.35%)

13:48
09/20/17
09/20
13:48
09/20/17
13:48
Periodicals
McConnell intends to consider healthcare bill in Senate next week, WSJ says »

A spokesman for Senate…

MOH

Molina Healthcare

$62.33

0.21 (0.34%)

UNH

UnitedHealth

$195.34

0.69 (0.35%)

CNC

Centene

$90.10

0.32 (0.36%)

WCG

WellCare

$166.10

-2.065 (-1.23%)

CI

Cigna

$181.44

-0.07 (-0.04%)

ANTM

Anthem

$181.90

0.46 (0.25%)

HNT

Health Net

HUM

Humana

$238.58

-1.46 (-0.61%)

AET

Aetna

$154.56

-1.48 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 24

    Oct

  • 08

    Nov

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.